Papazafiropoulou Athanasia, Daniil Ioannis, Sotiropoulos Alexios, Balampani Eleni, Kokolaki Anthi, Bousboulas Stavros, Konstantopoulou Stavroula, Skliros Eystathios, Petropoulou Dimitra, Pappas Stavros
3rd Department of Internal Medicine and Center of Diabetes, General Hospital of Nikaia "Ag, Panteleimon" - Piraeus, Greece.
BMC Res Notes. 2010 Jun 17;3:169. doi: 10.1186/1756-0500-3-169.
Diabetic subjects, especially women, show high prevalence of asymptomatic bacteriuria (ASB). The aim of the present study was to evaluate the prevalence of ASB in subjects with type 2 diabetes mellitus (T2D) with and without microalbuminuria (MA).
A hundred diabetic subjects with MA (53 males/47 females, mean age +/- standard deviation: 65.5 +/- 11.1 years) and 100 diabetic subjects without MA (52 males/48 females, mean age +/- standard deviation: 65.4 +/- 11.3 years), consecutively attending the outpatient diabetes clinic of our hospital were recruited in the study. Subjects with overt diabetic nephropathy or nephropathy from other causes were excluded. In addition, subjects with symptoms of urinary track infection or use of antimicrobial drugs in the last 14 days were excluded by the study.Diabetic subjects with MA showed increased prevalence of ASB compared to diabetic subjects without MA (21% versus 8%, P < 0.001, respectively). Escherichia coli was the most prevalent pathogen isolated in diabetic subjects with and without MA (12% versus 3.0%, P = 0.01, respectively) followed by Proteus mirabilis (6% versus 5%, P = 0.75, respectively) and Klebsiella spp (5% versus 1%, P = 0.09, respectively). Univariate logistic analysis showed that ASB was associated with the presence of coronary artery disease [odds ratio (OR): 0.29, 95% Confidence Intervals (95% CI): 0.09-0.95, P = 0.04] and gender (OR: 0.09, 95% CI: 0.02-0.35, P < 0.001) in the diabetic study group with MA.
ASB is more prevalent among T2D subjects with MA. Screening for ASB is warranted in diabetic patients especially if pyuria is detected in urine analysis since ASB has been found to be a risk factor for developing symptomatic urinary tract infection.
糖尿病患者,尤其是女性,无症状菌尿(ASB)的患病率较高。本研究的目的是评估有和无微白蛋白尿(MA)的2型糖尿病(T2D)患者中ASB的患病率。
本研究招募了我院门诊糖尿病诊所连续就诊的100例有MA的糖尿病患者(53例男性/47例女性,平均年龄±标准差:65.5±11.1岁)和100例无MA的糖尿病患者(52例男性/48例女性,平均年龄±标准差:65.4±11.3岁)。排除有显性糖尿病肾病或其他原因导致的肾病患者。此外,研究排除了有尿路感染症状或在过去14天内使用过抗菌药物的患者。与无MA的糖尿病患者相比,有MA的糖尿病患者ASB患病率更高(分别为21%和8%,P<0.001)。在有和无MA的糖尿病患者中,分离出的最常见病原体均为大肠埃希菌(分别为12%和3.0%,P=0.01),其次是奇异变形杆菌(分别为6%和5%,P=0.75)和克雷伯菌属(分别为5%和1%,P=0.09)。单因素逻辑回归分析显示,在有MA的糖尿病研究组中,ASB与冠状动脉疾病的存在[比值比(OR):0.29,95%置信区间(95%CI):0.09 - 0.95,P=0.04]和性别(OR:0.09,95%CI:0.02 - 0.35,P<0.001)相关。
ASB在有MA的T2D患者中更为普遍。糖尿病患者尤其是在尿液分析中检测到脓尿时,有必要筛查ASB,因为ASB已被发现是发生有症状尿路感染的危险因素。